These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 38279282)
1. Effect of β-Estradiol on Adipogenesis in a 3T3-L1 Cell Model of Prelamin A Accumulation. Cobelo-Gómez S; Sánchez-Iglesias S; Fernández-Pombo A; Araújo-Vilar D Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279282 [TBL] [Abstract][Full Text] [Related]
2. Site-dependent differences in both prelamin A and adipogenic genes in subcutaneous adipose tissue of patients with type 2 familial partial lipodystrophy. Araújo-Vilar D; Lattanzi G; González-Méndez B; Costa-Freitas AT; Prieto D; Columbaro M; Mattioli E; Victoria B; Martínez-Sánchez N; Ramazanova A; Fraga M; Beiras A; Forteza J; Domínguez-Gerpe L; Calvo C; Lado-Abeal J J Med Genet; 2009 Jan; 46(1):40-8. PubMed ID: 18805829 [TBL] [Abstract][Full Text] [Related]
3. Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction. Bidault G; Garcia M; Vantyghem MC; Ducluzeau PH; Morichon R; Thiyagarajah K; Moritz S; Capeau J; Vigouroux C; Béréziat V Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2162-71. PubMed ID: 23846499 [TBL] [Abstract][Full Text] [Related]
4. Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence. Caron M; Auclair M; Donadille B; Béréziat V; Guerci B; Laville M; Narbonne H; Bodemer C; Lascols O; Capeau J; Vigouroux C Cell Death Differ; 2007 Oct; 14(10):1759-67. PubMed ID: 17612587 [TBL] [Abstract][Full Text] [Related]
5. Itm2a silencing rescues lamin A mediated inhibition of 3T3-L1 adipocyte differentiation. Davies SJ; Ryan J; O'Connor PBF; Kenny E; Morris D; Baranov PV; O'Connor R; McCarthy TV Adipocyte; 2017 Oct; 6(4):259-276. PubMed ID: 28872940 [TBL] [Abstract][Full Text] [Related]
6. Drugs affecting prelamin A processing: effects on heterochromatin organization. Mattioli E; Columbaro M; Capanni C; Santi S; Maraldi NM; D'Apice MR; Novelli G; Riccio M; Squarzoni S; Foisner R; Lattanzi G Exp Cell Res; 2008 Feb; 314(3):453-62. PubMed ID: 18093584 [TBL] [Abstract][Full Text] [Related]
7. LMNA missense mutations causing familial partial lipodystrophy do not lead to an accumulation of prelamin A. Tu Y; Sánchez-Iglesias S; Araújo-Vilar D; Fong LG; Young SG Nucleus; 2016 Sep; 7(5):512-521. PubMed ID: 27841971 [TBL] [Abstract][Full Text] [Related]
8. An accumulation of non-farnesylated prelamin A causes cardiomyopathy but not progeria. Davies BS; Barnes RH; Tu Y; Ren S; Andres DA; Spielmann HP; Lammerding J; Wang Y; Young SG; Fong LG Hum Mol Genet; 2010 Jul; 19(13):2682-94. PubMed ID: 20421363 [TBL] [Abstract][Full Text] [Related]
9. Accumulation of distinct prelamin A variants in human diploid fibroblasts differentially affects cell homeostasis. Candelario J; Borrego S; Reddy S; Comai L Exp Cell Res; 2011 Feb; 317(3):319-29. PubMed ID: 20974128 [TBL] [Abstract][Full Text] [Related]
10. A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy. Araújo-Vilar D; Lado-Abeal J; Palos-Paz F; Lattanzi G; Bandín MA; Bellido D; Domínguez-Gerpe L; Calvo C; Pérez O; Ramazanova A; Martínez-Sánchez N; Victoria B; Costa-Freitas AT Clin Endocrinol (Oxf); 2008 Jul; 69(1):61-8. PubMed ID: 18031308 [TBL] [Abstract][Full Text] [Related]
11. Emerin-prelamin A interplay in human fibroblasts. Capanni C; Del Coco R; Mattioli E; Camozzi D; Columbaro M; Schena E; Merlini L; Squarzoni S; Maraldi NM; Lattanzi G Biol Cell; 2009 Sep; 101(9):541-54. PubMed ID: 19323649 [TBL] [Abstract][Full Text] [Related]
12. Abolishing the prelamin A ZMPSTE24 cleavage site leads to progeroid phenotypes with near-normal longevity in mice. Wang Y; Shilagardi K; Hsu T; Odinammadu KO; Maruyama T; Wu W; Lin CS; Damoci CB; Spear ED; Shin JY; Hsu W; Michaelis S; Worman HJ Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35197292 [TBL] [Abstract][Full Text] [Related]
13. The farnesyl transferase inhibitor (FTI) lonafarnib improves nuclear morphology in ZMPSTE24-deficient fibroblasts from patients with the progeroid disorder MAD-B. Odinammadu KO; Shilagardi K; Tuminelli K; Judge DP; Gordon LB; Michaelis S Nucleus; 2023 Dec; 14(1):2288476. PubMed ID: 38050983 [TBL] [Abstract][Full Text] [Related]
14. HIV protease inhibitors block adipocyte differentiation independently of lamin A/C. Kudlow BA; Jameson SA; Kennedy BK AIDS; 2005 Oct; 19(15):1565-73. PubMed ID: 16184025 [TBL] [Abstract][Full Text] [Related]
15. Prelamin A farnesylation and progeroid syndromes. Young SG; Meta M; Yang SH; Fong LG J Biol Chem; 2006 Dec; 281(52):39741-5. PubMed ID: 17090536 [TBL] [Abstract][Full Text] [Related]
16. The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation. Wojtanik KM; Edgemon K; Viswanadha S; Lindsey B; Haluzik M; Chen W; Poy G; Reitman M; Londos C J Lipid Res; 2009 Jun; 50(6):1068-79. PubMed ID: 19201734 [TBL] [Abstract][Full Text] [Related]
17. Impact of Progerin Expression on Adipogenesis in Hutchinson-Gilford Progeria Skin-Derived Precursor Cells. Najdi F; Krüger P; Djabali K Cells; 2021 Jun; 10(7):. PubMed ID: 34202258 [TBL] [Abstract][Full Text] [Related]